Condition: Plaque Psoriasis · Sponsor: Bristol-Myers Squibb
The purpose of this study is to evaluate the efficacy, safety, and drug levels of Deucravacitinib (BMS-986165) in adolescent participants with moderate to severe plaque psoriasis
This description comes directly from the study's public registry record.
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com · 855-907-3286 · Clinical.Trials@bms.com
First line of the email MUST contain NCT # and Site #.
Always discuss trial participation with your own doctor first.
| Local Institution - 0261 | Birmingham, Alabama, United States | Not Yet Recruiting |
| Local Institution - 0041 | Birmingham, Alabama, United States | Not Yet Recruiting |
| Local Institution - 0053 | Phoenix, Arizona, United States | Active Not Recruiting |
| Local Institution - 0025 | Fountain Valley, California, United States | Not Yet Recruiting |
| Center For Dermatology Clinical Research, Inc. | Fremont, California, United States | Recruiting |
| Dermatology Research Associates | Los Angeles, California, United States | Recruiting |
| Northridge Clinical Trials | Northridge, California, United States | Recruiting |
| Local Institution - 0077 | Sacramento, California, United States | Not Yet Recruiting |
| Golden State Dermatology - Walnut Creek - Ygnacio Valley Road | Walnut Creek, California, United States | Recruiting |
| Paradigm Clinical Research, LLC | Wheat Ridge, Colorado, United States | Recruiting |
| Local Institution - 0021 | Clearwater, Florida, United States | Not Yet Recruiting |
| Life Clinical Trials | Margate, Florida, United States | Recruiting |
+ 117 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06979453